Inventor · disambiguated record
Thierry Bonnaud
Also filed as: BONNAUD THIERRY
14 granted patents·22 pending applications·63 citations·filing 2005–2024
91Inventor score
Files withJOHNSON MATTHEY PLC6PHARMACYCLICS LLC6NEUROCRINE BIOSCIENCES INC4SPERO THERAPEUTICS INC4MYCOVIA PHARMACEUTICALS INC3
Top patents by PatentIndex Score
36 records- 0197US9840492B2Antifungal compounds and processes for makingVIAMET PHARMACEUTICALS INC·Filed 2016·Granted Dec 12, 2017·17 cites·6 claims
- 0295US10065952B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2016·Granted Sep 4, 2018·30 cites·17 claims
- 0390US10851103B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 1, 2020·2 cites·27 claims
- 0490US10851104B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 1, 2020·2 cites·29 claims
- 0590US10844058B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Nov 24, 2020·2 cites·27 claims
- 0687US10414751B2Antifungal compounds and processes for makingMYCOVIA PHARMACEUTICALS INC·Filed 2019·Granted Sep 17, 2019·2 cites·12 claims
- 0783US2025051334A1Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0882US12098155B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·0 cites·16 claims
- 0979US10889587B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2018·Granted Jan 12, 2021·1 cites·16 claims
- 1078US10676459B2Antifungal compounds and processes for makingMYCOVIA PHARMACEUTICALS INC·Filed 2019·Granted Jun 9, 2020·1 cites·12 claims
- 1176US10370353B2Antifungal compounds and processes for makingMYCOVIA PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·1 cites·11 claims
- 1276US8536196B2Substituted 1,3-dioxanes useful as PPAR modulatorsSORENSEN ALEXANDRA SANTANA·Filed 2008·Granted Sep 17, 2013·4 cites·19 claims
- 1375US2020347063A1Solvated forms of a bruton?s tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 1472US11718621B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2020·Granted Aug 8, 2023·0 cites·16 claims
- 1572US2022106317A1Solvated forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 1670US2022033408A1Process for preparing spiro derivativesBIOGEN INC·Filed 2021·Application pending·0 cites
- 1769US2022242868A1Co-crystals of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 1867US7915300B2Cysteine protease inhibitorsMEDIVIR AB·Filed 2005·Granted Mar 29, 2011·1 cites·29 claims
- 1963US11149039B2Process for preparing spiro derivativesBIOGEN INC·Filed 2018·Granted Oct 19, 2021·0 cites·19 claims
- 2061US2019367519A1Solvated forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 2160US2021094930A1Coformer salts of (2s,3s)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1h-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate and methods of preparing themMEDIVATION TECH LLC·Filed 2020·Application pending·0 cites
- 2258US2020031829A1Co-crystals of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 2358US2019106401A1Coformer salts of (2s,3s)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1h-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate and methods of preparing themMEDIVATION TECH LLC·Filed 2018·Application pending·0 cites
- 2454US2018072738A1Solvated forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 2553US2021361626A1Crystalline productJOHNSON MATTHEY PLC·Filed 2021·Application pending·0 cites
- 2652US2022369641A1Molecular complexesJOHNSON MATTHEY PLC·Filed 2020·Application pending·0 cites
- 2751US2024239748A1Novel forms of entinostatMACFARLAN SMITH LTD·Filed 2022·Application pending·0 cites
- 2851US2023068593A1Processes for preparing tucatinib polymorphsMACFARLAN SMITH LTD·Filed 2022·Application pending·0 cites
- 2949US2018072739A1Co-crystals of a bruton's tyrosine kinase inhibitorPharmacyclic LLC·Filed 2016·Application pending·0 cites
- 3049US2017217921A1Coformer salts of (2s,3s)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1h-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate and methods of preparing themMEDIVATION TECHNOLOGIES INC·Filed 2015·Application pending·0 cites
- 3148US2022289682A1Molecular complexesJOHNSON MATTHEY PLC·Filed 2020·Application pending·0 cites
- 3246US2023126277A1Crystalline forms of Voxelotor, and Processes for the Preparation ThereofJOHNSON MATTHEY PLC·Filed 2021·Application pending·0 cites
- 3345US2022372024A1Crystalline forms of entrectinibJOHNSON MATTHEY PLC·Filed 2020·Application pending·0 cites
- 3441US2022275004A1Molecular complexesJOHNSON MATTHEY PLC·Filed 2020·Application pending·0 cites
- 3541US2024124458A1Polymorphs of avapritinib and methods for preparing the polymorphsMacfarlan Smith Limted·Filed 2020·Application pending·0 cites
- 3640US2011112089A1Cysteine Protease InhibitorsMEDIVIR AB·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thierry Bonnaud files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →